Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mereo BioPharma (MREO) Cash from Investing Activities (2023 - 2025)

Historic Cash from Investing Activities for Mereo BioPharma (MREO) over the last 3 years, with Q3 2025 value amounting to $300000.0.

  • Mereo BioPharma's Cash from Investing Activities changed N/A to $300000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$20000.0, marking a year-over-year increase of 9713.88%. This contributed to the annual value of -$699000.0 for FY2024, which is 6682.58% down from last year.
  • Mereo BioPharma's Cash from Investing Activities amounted to $300000.0 in Q3 2025.
  • Over the past 5 years, Mereo BioPharma's Cash from Investing Activities peaked at $300000.0 during Q3 2025, and registered a low of -$700000.0 during Q1 2024.
  • In the last 3 years, Mereo BioPharma's Cash from Investing Activities had a median value of -$320000.0 in 2025 and averaged -$227600.0.
  • Its Cash from Investing Activities has fluctuated over the past 5 years, first tumbled by 6706.44% in 2024, then surged by 5428.57% in 2025.
  • Over the past 3 years, Mereo BioPharma's Cash from Investing Activities (Quarter) stood at -$419000.0 in 2023, then soared by 100.24% to $1000.0 in 2024, then soared by 29900.0% to $300000.0 in 2025.
  • Its last three reported values are $300000.0 in Q3 2025, -$320000.0 for Q1 2025, and $1000.0 during Q2 2024.